The Oncology Institute, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
74.91 | 48.77 | 53.61% | -2.55 | -3 032.92% |
| P/S |
|
0.4617 | 33.76 | -98.63% |
|
|
| P/BV |
|
2.63 | 4.82 | -45.54% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-4.36 | -22.15 | -80.33% |
|
|
| Ev/S |
|
0.728 | 22.56 | -96.77% |
|
|
| Ev/FCF |
|
-5.77 | 68.78 | -108.39% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-16.7 | 4.98 | -435.65% | -8.93 | +87.06% |
| ROE |
|
-119.03 | 9.61 | -1338.4% |
|
|
| ROA |
|
-30.94 | 0.3443 | -9085.96% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-20.93 | -25.17 | -16.85% |
|
|
| ROCE |
|
-105.28 | 15.35 | -785.86% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.72 | -3.68 | -53.17% | 1.55 | -211.34% |
| Nеt Debt/Ebitda |
|
-1.59 | -3.44 | -53.62% |
|
|
| Debt/Ratio |
|
0.4249 | 0.1985 | 114.07% |
|
|
| Debt/Equity |
|
10.97 | 1.66 | 559.84% |
|
|
| Debt/Net Income |
|
-1.37 | 10.32 | -113.3% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
103.86 | 43.56 | 138.4% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
108.65 | -56.89 | -290.98% | ||
| Growth impulse Ebitda in 5 years |
|
-23049.19 | -54.68 | 42052.87% | ||
| Growth impulse Net Income in 5 years |
|
1976.7 | -58.33 | -3488.82% | ||
| Growth impulse FCF in 5 years |
|
-1803.42 | -49.48 | 3544.75% | ||
| Growth impulse EPS in 5 years |
|
1705.07 | -32.41 | -5360.94% |
IP Score
4.23/10
